Free Trial

Nurix Therapeutics (NRIX) SEC Filings & 10K Form

Nurix Therapeutics logo
$22.92 -3.94 (-14.67%)
(As of 11/15/2024 ET)

Recent Nurix Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
8:00 PM
Nurix Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
11:48 AM
Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
4:37 PM
MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G/A
11/04/2024
4:48 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:57 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:57 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:50 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:41 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:36 PM
Nurix Therapeutics (Filer)
Form 424B5
10/31/2024
3:12 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
3:01 PM
Nurix Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/30/2024
7:30 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:30 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:30 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:41 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:47 PM
Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2024
3:48 PM
Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:16 AM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
3:05 PM
Nurix Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
6:36 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:32 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
6:01 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
4:33 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:28 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
5:23 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:41 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:24 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:25 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
6:06 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:06 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:31 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
6:06 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
6:06 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
6:06 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:06 PM
Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:45 PM
Nurix Therapeutics (Filer)
Form 424B5
07/01/2024
5:35 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
2:23 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
6:02 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:39 PM
Nurix Therapeutics (Issuer)
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
06/12/2024
6:30 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G/A
06/05/2024
5:01 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
5:36 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
6:06 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
6:25 PM
Nurix Therapeutics (Issuer)
Saltzman Edward C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:25 PM
Nurix Therapeutics (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:25 PM
Lacey David L. (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:25 PM
GREGORY JULIA P (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:26 PM
Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:26 PM
Nurix Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
5:01 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:19 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
5:33 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:33 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
5:33 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
4:10 PM
Nurix Therapeutics (Filer)
Form 424B5
04/12/2024
4:12 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:06 PM
Nurix Therapeutics (Filer)
Form 424B5
04/10/2024
6:02 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
6:06 AM
Nurix Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2024
12:17 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
6:01 AM
Nurix Therapeutics (Filer)
Form DEF 14A
03/27/2024
6:02 AM
Nurix Therapeutics (Filer)
Form DEFA14A
03/27/2024
6:03 AM
Nurix Therapeutics (Filer)
Form ARS
03/11/2024
6:02 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
6:20 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:22 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:51 PM
Nurix Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/15/2024
6:22 AM
Nurix Therapeutics (Issuer)
SANDS ARTHUR T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
6:23 AM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
6:23 AM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
6:23 AM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:51 AM
Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G/A
02/14/2024
7:00 AM
Nurix Therapeutics (Subject)
SANDS ARTHUR T (Filed by)
Form SC 13G
02/09/2024
12:47 PM
MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G
02/09/2024
12:56 PM
Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
01/30/2024
5:52 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:52 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:53 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G/A
01/23/2024
9:28 AM
Nurix Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
6:03 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
4:19 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:55 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
11:03 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRIX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners